Literature DB >> 10727979

The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle.

D E MacCallum1, P A Hall.   

Abstract

Although widely used as a marker of cell proliferation, the biochemical properties and function of the Ki67 antigen remain poorly understood. Recent data indicate that it can interact with RNA, DNA, and a number of cellular proteins including elements of the ubiquitin proteolytic pathway and a novel kinase. The evidence for its expression only in cycling cells is extensive and it is not regulated by stress, apoptosis or DNA damage. It was reasoned that a detailed characterization of the localization of pKi67 and analysis of its spatial relationship to other nucleolar proteins may provide insights into its function. Using high-resolution laser scanning confocal microscopy with double and triple labelling, pKi67 expression in MCF7 cells has been defined in relation to the distribution of nucleolin, fibrillarin, p130 (human Nopp 140 homologue), p120 (Nol 1), RH-II/Gu helicase, and topoisomerase II beta. All of these molecules are perichromosomal during mitosis and all but fibrillarin and p130 show extra-nucleolar distribution in early G1. The majority of p120 (Nol 1) and RH-II/Gu helicase co-localize in the diffuse fibrillar centre (DFC) of nucleoli, while there is only partial overlap with nucleolin and fibrillarin. There is no co-localization between p130 and pKi67. These data refine current understanding of the distribution of pKi67 and its physical relationship with functional domains of the nucleolus and place pKi67 in a zone of the DFC associated with late rRNA processing. Taken together with recent biochemical data, these observations allow the proposal of a model of pKi67 function in which it acts as an 'efficiency factor' in ribosome biogenesis during the heavy metabolic demands placed on a cell during the cell division cycle. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727979     DOI: 10.1002/(SICI)1096-9896(200004)190:5<537::AID-PATH577>3.0.CO;2-W

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  36 in total

1.  Comparison of Ki-67 equivalent antibodies.

Authors:  C F Lindboe; S H Torp
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

Review 2.  Cell cycle regulation to repair the infarcted myocardium.

Authors:  Joshua D Dowell; Loren J Field; Kishore B S Pasumarthi
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

3.  Analysis of human Ki-67 gene promoter and identification of the Sp1 binding sites for Ki-67 transcription.

Authors:  Dong-Sheng Pei; Guo-Wei Qian; Hui Tian; Jie Mou; Wang Li; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2011-11-29

4.  Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart.

Authors:  A Leri; L Barlucchi; F Limana; A Deptala; Z Darzynkiewicz; T H Hintze; J Kajstura; B Nadal-Ginard; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

Review 5.  The perichromosomal layer.

Authors:  Aaron A Van Hooser; Patrick Yuh; Rebecca Heald
Journal:  Chromosoma       Date:  2005-11-15       Impact factor: 4.316

6.  Acute myocardial infarction induced functional cardiomyocytes to re-enter the cell cycle.

Authors:  Yongjun Li; Shengda Hu; Genshan Ma; Yuyu Yao; Gaoliang Yan; Jia Chen; Yefei Li; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2013-04-19       Impact factor: 4.060

7.  Ki67 antigen contributes to the timely accumulation of protein phosphatase 1γ on anaphase chromosomes.

Authors:  Masatoshi Takagi; Yuko Nishiyama; Atsuko Taguchi; Naoko Imamoto
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

8.  Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps.

Authors:  Yu Zhang; Yifeng Zhu; Kai Zhang; Yajie Liu; Jingjing Cui; Juan Tao; Yingzi Wang; Shaowu Wang
Journal:  Radiol Med       Date:  2019-11-06       Impact factor: 3.469

9.  Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

Authors:  Pankaj Taneja; Dejan Maglic; Fumitake Kai; Sinan Zhu; Robert D Kendig; Elizabeth A Fry; Kazushi Inoue
Journal:  Clin Med Insights Oncol       Date:  2010-04-20

10.  Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma.

Authors:  M Losa; A Vimercati; S Acerno; R L Barzaghi; P Mortini; F Mangili; M R Terreni; G Santambrogio; M Giovanelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.